Workcell Solutions Private Limited

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Workcell Solutions Private Limited - overview

Established

2014

Location

Mumbai, Maharashtra, India

Primary Industry

Retail

About

Workcell Solutions Private Limited, based in Mumbai, India, specializes in innovative healthcare solutions, focusing on enhancing patient access to essential medications through a robust online platform. Founded in 2014 in Mumbai, India, Workcell Solutions Private Limited provides an integrated healthcare delivery model. The company has successfully completed 7 deals, with its most recent funding round being a SERIES B raising INR 923. 87 mn in December 2021.


Investors include Toy Ventures, Whiteboard Capital, Alteria Capital, and Lightbox Ventures. The founders, Girish Agarwal and Siddharth Gadia, have been instrumental in the company's growth, which currently holds a valuation of INR 7574. 54 mn. Workcell Solutions Private Limited offers a comprehensive range of healthcare products and services aimed at improving patient access to essential medications.


The company’s online platform connects patients with a diverse selection of medical products, addressing the need for affordable medications for both chronic and acute health conditions. Their services streamline the procurement process, particularly for individuals in urban areas. In 2023, Workcell Solutions Private Limited reported a revenue of INR 16,402,844. 40, with an EBITDA of INR -7,320,200.


70. Following the recent SERIES B funding round in December 2021, which raised INR 923. 87 mn, Workcell Solutions Private Limited plans to leverage this capital to enhance its technology and expand its reach into new markets. The company is focusing on launching new healthcare products designed to meet specific patient needs and aims to enter additional geographic regions by the end of 2023.


Their strategic initiatives will further solidify the company’s position in the healthcare sector.


Current Investors

Whiteboard Capital, Tomorrow Capital, Alteria Capital

Primary Industry

Retail

Sub Industries

Drug Stores/Convenience Stores, Pharmaceuticals

Website

www.generico.in

Company Stage

Mature

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.